PBMT on Muscular Performance and Recovery in Different Time-points
NCT ID: NCT03420391
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-05-20
2019-07-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Photobiomodulation Therapy in Strength Training and Detraining in Humans
NCT03858179
Effect of Whole-body Photobiomodulation on Muscular Performance Enhancement.
NCT05989815
Effects of Photobiomodulation Therapy in Aerobic Training and Detraining in Humans
NCT03879226
Local and Systemic Effects of Photobiomodulation Therapy on Muscle Performance and Recovery Post-exercise.
NCT03695458
Phototherapy Applied in Association With Muscular Training
NCT02715050
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Control: Participants will receive no intervention; Placebo: Participants will receive placebo PBMT; 5 minutes: Participants will perform the eccentric exercise protocol 5 minutes after PBMT.
3 hours: Participants will perform the eccentric exercise protocol 3 hours after PBMT.
6 hours: Participants will perform the eccentric exercise protocol 6 hours after PBMT.
24 hours: Participants will perform the eccentric exercise protocol 24 hours after PBMT.
Assessments will be performed at baseline, after 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo PBMT
Participants will be treated with placebo PBMT in different time-points before the eccentric exercise protocol (5 minutes, 3 hours, 6 hours or 24 hours). Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.
Photobiomodulation Therapy (PBMT)
Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)
5 Minutes
Participants will be performed the eccentric exercise protocol 5 minutes after PBMT.
Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.
Photobiomodulation Therapy (PBMT)
Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)
3 Hours
3 hours: Participants will be performed the eccentric exercise protocol 3 hours after PBMT.
Assessments will be performed before at baseline, 1 minute, 1 hour and 24, 48 hours after the end of exercise protocol.
Photobiomodulation Therapy (PBMT)
Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)
6 Hours
6 hours: Participants will be performed the eccentric exercise protocol 6 hours after PBMT.
Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.
Photobiomodulation Therapy (PBMT)
Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)
24 hours
24 hours: Participants will be performed the eccentric exercise protocol 24 hours after PBMT. Assessments will be performed before at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.
Photobiomodulation Therapy (PBMT)
Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)
Control
Participants will not receive intervention. Assessments will be performed at baseline, 1 minute, 1 hour, 24 and 48 hours after the end of exercise protocol.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Photobiomodulation Therapy (PBMT)
Phototherapy device - Multi Radiance Medical® (Solon, OH, EUA)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* not athletes or who engage in physical activity at most once a week
* Individuals should not present a history of musculoskeletal injury in the hip and knee regions in the two months prior to the studies
* they should not be using pharmacological agents and / or nutritional supplements
* They must attend 100% of the data collections.
Exclusion Criteria
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
University of Bergen
OTHER
University of Nove de Julho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ernesto Cesar Pinto Leal Junior
Full professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Nove de Julho
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Leal-Junior ECP, de Oliveira MFD, Joensen J, Stausholm MB, Bjordal JM, Tomazoni SS. What is the optimal time-response window for the use of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) for the improvement of exercise performance and recovery, and for how long the effects last? A randomized, triple-blinded, placebo-controlled trial. BMC Sports Sci Med Rehabil. 2020 Oct 19;12:64. doi: 10.1186/s13102-020-00214-8. eCollection 2020.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
113553
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.